Clinical Trial Update: Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins

View source ↗

Summary

A Pfizer-sponsored trial in invasive candidiasis evaluated the risk of severe hepatic injury with echinocandins. The study was terminated and its results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• Anidulafungin (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Invasive Candidiasis, Candidemia | Status: TERMINATED | Results posted: 2016-02-04